ID: ALA2079652

Max Phase: Preclinical

Molecular Formula: C8H17NO

Molecular Weight: 143.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC[C@@H](O)C1CCCCC1

Standard InChI:  InChI=1S/C8H17NO/c9-6-8(10)7-4-2-1-3-5-7/h7-8,10H,1-6,9H2/t8-/m1/s1

Standard InChI Key:  MSIAFRBGOYFCND-MRVPVSSYSA-N

Associated Targets(non-human)

Phenylethanolamine N-methyltransferase 752 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 143.23Molecular Weight (Monoisotopic): 143.1310AlogP: 0.89#Rotatable Bonds: 2
Polar Surface Area: 46.25Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.58CX LogP: 0.86CX LogD: -1.27
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.60Np Likeness Score: 0.85

References

1. Rafferty MF, Wilson DS, Monn JA, Krass P, Borchardt RT, Grunewald GL..  (1982)  Importance of the aromatic ring in adrenergic amines. 7. Comparison of the stereoselectivity of norepinephrine N-methyltransferase for aromatic vs. nonaromatic substrates and inhibitors.,  25  (10): [PMID:7143356] [10.1021/jm00352a020]

Source